{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:00:07Z","timestamp":1758970807489,"version":"3.37.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf03165037","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T05:22:41Z","timestamp":1254288161000},"page":"119-123","source":"Crossref","is-referenced-by-count":6,"title":["Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys"],"prefix":"10.1007","volume":"9","author":[{"given":"Nobuaki","family":"Hayase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Tomiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushige","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Ohye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03165037_CR1","first-page":"19","volume-title":"Parkinson\u2019s disease. Advances in Neurology, vol. 45","author":"O Hornykiewicz","year":"1986","unstructured":"Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson\u2019s disease.In Parkinson\u2019s disease. Advances in Neurology, vol. 45, Yahr MD, Bergmenn KJ (eds.), New York, Raven Press, pp. 19\u201334, 1986."},{"key":"BF03165037_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/305137a0","volume":"305","author":"ES Garnett","year":"1983","unstructured":"Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia ofliving man. Nature 305: 137\u2013138, 1983.","journal-title":"Nature"},{"key":"BF03165037_CR3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","volume":"47","author":"KL Leenders","year":"1990","unstructured":"Leenders KL, Salmon EP, Tyrrell P, Perani D, Brooks DJ, Sager H, et al. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomograph in healthy volunteer subjects and patients with Parkinson\u2019s disease.Arch Neurol 47: 1290\u20131298, 1990","journal-title":"Arch Neurol"},{"key":"BF03165037_CR4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410260407","volume":"26","author":"WRW Martin","year":"1989","unstructured":"Martin WRW, Palmer MR, Patlak CS, Calne DB. Nigrostriatal function in human studied with positron emission tomograph.Ann Neurol 26: 535\u2013542, 1989","journal-title":"Ann Neurol"},{"key":"BF03165037_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.410280412","volume":"28","author":"DJ Brooks","year":"1990","unstructured":"Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, et al. Differing patterns of striatal18F-dopa uptake in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy.Ann Neurol 28: 547\u2013555, 1990.","journal-title":"Ann Neurol"},{"key":"BF03165037_CR6","first-page":"51","volume":"94","author":"M Guttman","year":"1988","unstructured":"Guttman M, Young VW, Kim SU, Calne DB, Martin WR, Adam MJ, et al. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.Synapse 94: 51\u201367, 1988.","journal-title":"Synapse"},{"key":"BF03165037_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00230688","volume":"78","author":"DJ Doudet","year":"1989","unstructured":"Doudet DJ, Miake H, Finn RT, McLellan CA, Aigner TG, Wan RQ, et al. 6-18F-L-DOPA imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkey.Exp Brain Res 78: 69\u201380, 1989.","journal-title":"Exp Brain Res"},{"key":"BF03165037_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/317246a0","volume":"317","author":"DB Calne","year":"1985","unstructured":"Calne DB. Langston JW, Martin WRW, Stoessl AJ, Ruth TJ, Adam MJ, et al. Positron emission tomograph after MPTP: observations relating to the cause of Parkinson\u2019s disease.Nature 317: 246\u2013248, 1985.","journal-title":"Nature"},{"key":"BF03165037_CR9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.1987.tb05629.x","volume":"48","author":"G Firnau","year":"1987","unstructured":"Firnau G, Sood S, Chirakal R, Nahmias C, Garnett ES. Cerebral metabolism of 6-[18F]-l,3,4-dihydroxyphenylalanine in the primate.JNeurochem 48: 1077\u20131082, 1987.","journal-title":"JNeurochem"},{"key":"BF03165037_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jnr.490270408","volume":"27","author":"JR Barrio","year":"1990","unstructured":"Barrio JR, Huang SC, Melega DC, Yu DC, Hoffman JM, Schnider JS, et al. 6-[18F]Fluoro-L-DOPA probes dopamine turnover rates in cerebral dopaminergic structures.J Neurosci Res 27: 487\u2013493, 1990.","journal-title":"J Neurosci Res"},{"key":"BF03165037_CR11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0006-291X(88)90732-2","volume":"150","author":"OT DeJesus","year":"1988","unstructured":"DeJesus OT, Mukherjee J. Radiobrominated m-tyrosine analog as potential CNS 1-dopa PET tracer.Biochem Bioph Res Commun 150: 1027\u20131031, 1988.","journal-title":"Biochem Bioph Res Commun"},{"key":"BF03165037_CR12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1471-4159.1989.tb07331.x","volume":"53","author":"WP Melega","year":"1989","unstructured":"Melega WP, Perlmutter MM, Luxen A, Nissenson CHK, Grafton ST, Huang S-C, et al. 3-[18F]Fluoro-L-m-tyrosine: a L-3,4-dihydroxy-phenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography.J Neurochem 53: 311\u2013314, 1989.","journal-title":"J Neurochem"},{"key":"BF03165037_CR13","first-page":"902","volume":"31","author":"OT Jesus De","year":"1990","unstructured":"DeJesus OT, Murali D, Sunderland JJ, Chen C-A, Weiler M, Nickles RJ. [18F]Fluoro-MDL 72394, A potentially trappable tracer for presynaptic dopamine neurons.J Nucl Med 31: 902, 1990.","journal-title":"J Nucl Med"},{"key":"BF03165037_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(92)91518-J","volume":"597","author":"OT Jesus De","year":"1992","unstructured":"DeJesus OT, Holden JE, Endres C, Murali D, Oakes TR, Shelton S, et al. Visualization of dopamine nerve terminals by positron emission tomograph using [18F]fluoro-\u03b2-fluorornethylene-m-tyrosine.Brain Res 597: 151\u2013154, 1992.","journal-title":"Brain Res"},{"key":"BF03165037_CR15","first-page":"272","volume":"28","author":"G Firnau","year":"1991","unstructured":"Firnau G, Chirakal ES, Nahmias C, Garnett ES. [18F]Fluorometa-L-tyrosine is a better PET tracer that [18F]fluoro-LDOPA for the delineation of dopaminergic structures in the human brain.J Labe Comp Radio Pharm 28: 272\u2013273, 1991.","journal-title":"J Labe Comp Radio Pharm"},{"issue":"5","key":"BF03165037_CR16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","volume":"3","author":"A Ballard","year":"1985","unstructured":"Ballard A, Tetrud JW, Langstom JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.Neurology 3: 5: 949\u2013956, 1985.","journal-title":"Neurology"},{"key":"BF03165037_CR17","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methl-4-phenyl-1,2,3, 6-tetrahydropridine.Proc Natl Acad Sci USA 80: 4546\u20134550, 1983.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03165037_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","volume":"39","author":"KS Bankiewicz","year":"1986","unstructured":"Bankiewicz KS, Oldfield EH, Chiuh CC, Doppman JL, Jacobowitz DM, Kopin IJ. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP).Life Sci 39: 7\u201316, 1986.","journal-title":"Life Sci"},{"key":"BF03165037_CR19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.42.8.1565","volume":"42","author":"JS Schneider","year":"1992","unstructured":"Schneider JS, McLaughlin WW, Roelten DP. Motor and nonmotor behavioral deficits in monkeys made hemiparkinsonian by intracarotid MPTP infusion.Neurology 42: 1565\u20131572, 1992.","journal-title":"Neurology"},{"key":"BF03165037_CR20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/brain\/111.6.1265","volume":"111","author":"JS Schneider","year":"1988","unstructured":"Schneider JS, Unguez G, Ywiler A, Berg SC, Markham CH. Deficits in operant behavior in monkeys treated with Nmethyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP).Brain 111: 1265\u20131285, 1988.","journal-title":"Brain"},{"key":"BF03165037_CR21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0883-2889(90)90056-M","volume":"41","author":"M Perlmutter","year":"1990","unstructured":"Perlmutter M, Satyamurthy N, Luxen AM, Phelps E, Barrio JR. Synthesis of 4-[18F]Fluoro-L-m-tyrosine: a model analog for thein vivo assessment of central dopaminergic function.Appl Radiat Isot 41: 801\u2013807, 1990.","journal-title":"Appl Radiat Isot"},{"key":"BF03165037_CR22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0883-2889(90)90001-W","volume":"41","author":"OT Jesus De","year":"1990","unstructured":"DeJesus OT, Sunderland JJ, Nickless JR, Mukherjee J, Appelman EH. Synthesis of radiofluorinated analogs of mtyrosine as potential L-dopa tracers via direct reaction with acetylhypofluorite.Int J Rad Appl Instrum A 41: 433\u2013437, 1990.","journal-title":"Int J Rad Appl Instrum A"},{"key":"BF03165037_CR23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1109\/TNS.1985.4336947","volume":"32","author":"N Ohara","year":"1985","unstructured":"Ohara N, Tanaka E, Tomitani T. Analytical study of performance of high resolution positron emission computed tomography for animal study.IEEE Trans Nucl Sci 32: 818\u2013822, 1985.","journal-title":"IEEE Trans Nucl Sci"},{"key":"BF03165037_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-510X(89)90117-2","volume":"90","author":"CE Clarke","year":"1989","unstructured":"Clarke CE, Boyes S, Robertson RG, Sambrook MA, Crossman AR. Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP).J Neurol Sci 90: 307\u2013314, 1989.","journal-title":"J Neurol Sci"},{"key":"BF03165037_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0031-6997(25)06681-5","volume":"27","author":"HC Guldberg","year":"1975","unstructured":"Guldberg HC, Marsden CA. Catecol-o-methyl transferase: pharmacological aspects and physiological role.Phermacol Rev 27: 135\u2013206, 1975.","journal-title":"Phermacol Rev"},{"key":"BF03165037_CR26","first-page":"597","volume":"526","author":"K Srinivasan","year":"1978","unstructured":"Srinivasan K, Awapara J. Substrate specificity and other properties of DOPA decarboxylase from guinea pig kidneys.Biochem Biophys Acta 526: 597\u2013604, 1978.","journal-title":"Biochem Biophys Acta"},{"key":"BF03165037_CR27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0014-2999(73)90231-8","volume":"21","author":"U Ungerstedt","year":"1973","unstructured":"Ungerstedt U, Fuxe K, Goldstein M, Battista A, Ogawa M, Anagnoste B. Action of m-tyrosine in experimental models: evidence for possible antiparkinsonian activity.Eur J Pharmacol 21: 230\u2013237, 1973.","journal-title":"Eur J Pharmacol"},{"key":"BF03165037_CR28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0006-2944(79)90010-3","volume":"22","author":"V Fell","year":"1979","unstructured":"Fell V, Greenway AM, Hoskins JA. The metabolism of L-m-tyrosine in man.Biochem Med 22: 246\u2013255, 1979.","journal-title":"Biochem Med"},{"key":"BF03165037_CR29","first-page":"1215","volume":"14","author":"J Kopin","year":"1988","unstructured":"Kopin J, Zuddas A, Weise V, Plunkett RJ, Oldfield EH, Bankiewicz KS. Dopamine and tyrosine hydroxylase levels in the cortical and subcortical area in the MPTP-parkinsonian monkeys.Neurosci Abstr 14: 1215, 1988.","journal-title":"Neurosci Abstr"},{"issue":"1","key":"BF03165037_CR30","first-page":"378","volume":"41","author":"RS Burns","year":"1991","unstructured":"Burns RS, Nashville TN, Kopin I, Weiss V. Decreased LAAAD in striatum influences brain LDOPA metabolism in MPTP treated rhesus monkey with severe Parkinsonism.Neurology 41 (Suppl 1): 378, 1991.","journal-title":"Neurology"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03165037\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T12:27:14Z","timestamp":1739363234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03165037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF03165037"],"URL":"https:\/\/doi.org\/10.1007\/bf03165037","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}